论文标题
贝叶斯非参数方法,用于推断艾滋病毒患者对心理健康的影响
A Bayesian Nonparametric Approach for Inferring Drug Combination Effects on Mental Health in People with HIV
论文作者
论文摘要
尽管抗逆转录病毒疗法(ART)在抑制艾滋病毒(PWH)的病毒负荷方面非常有效,但许多艺术药物可能会加剧中枢神经系统(CNS)相关的不良反应,包括抑郁症。因此,了解艺术药物对中枢神经系统功能的影响,尤其是心理健康,可以帮助临床医生个性化对PWH的不利影响,并阻止其停用其艺术,以避免不良的健康结果并增加HIV传播的可能性。电子健康记录的出现为研究人员提供了前所未有的访问HIV数据,包括个人心理健康记录,药物处方和随着时间的推移临床信息。但是,由于药物组合空间的高维,个体异质性和观察到的药物组合的稀疏性,对此类数据进行建模非常具有挑战性。我们开发了一种贝叶斯非参数方法来学习对PWH的心理健康的影响,以调整社会人口统计学,行为和临床因素。所提出的方法建立在子集树核法基于代表药物组合的子集-Tree核法,该方法以将已知方案结构合成为单个数学表示形式的方式。它还利用距离依赖的中国餐厅过程来集群异质种群,同时考虑到个人的治疗历史。我们通过模拟研究评估了提出的方法,并将该方法应用于妇女间艾滋病毒艾滋病毒研究的数据集,从而产生可解释且有希望的结果。我们的方法具有指导临床医生根据个人的治疗史和临床特征开出更有效和有效的个性化治疗方法的临床实用性。
Although combination antiretroviral therapy (ART) is highly effective in suppressing viral load for people with HIV (PWH), many ART agents may exacerbate central nervous system (CNS)-related adverse effects including depression. Therefore, understanding the effects of ART drugs on the CNS function, especially mental health, can help clinicians personalize medicine with less adverse effects for PWH and prevent them from discontinuing their ART to avoid undesirable health outcomes and increased likelihood of HIV transmission. The emergence of electronic health records offers researchers unprecedented access to HIV data including individuals' mental health records, drug prescriptions, and clinical information over time. However, modeling such data is very challenging due to high-dimensionality of the drug combination space, the individual heterogeneity, and sparseness of the observed drug combinations. We develop a Bayesian nonparametric approach to learn drug combination effect on mental health in PWH adjusting for socio-demographic, behavioral, and clinical factors. The proposed method is built upon the subset-tree kernel method that represents drug combinations in a way that synthesizes known regimen structure into a single mathematical representation. It also utilizes a distance-dependent Chinese restaurant process to cluster heterogeneous population while taking into account individuals' treatment histories. We evaluate the proposed approach through simulation studies, and apply the method to a dataset from the Women's Interagency HIV Study, yielding interpretable and promising results. Our method has clinical utility in guiding clinicians to prescribe more informed and effective personalized treatment based on individuals' treatment histories and clinical characteristics.